View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsC-Lab 過去の業績過去 基準チェック /06C-Labは0.05%の年平均成長率で業績を伸ばしているが、Tech業界はgrowingで6.6%毎年増加している。売上は減少しており、年平均0.2%の割合である。主要情報0.045%収益成長率-0.52%EPS成長率Tech 業界の成長11.81%収益成長率-0.21%株主資本利益率-3.45%ネット・マージン-3.43%前回の決算情報30 Jun 2025最近の業績更新Reported Earnings • Mar 27Full year 2024 earnings released: EPS: ₪0.34 (vs ₪2.42 in FY 2023)Full year 2024 results: EPS: ₪0.34 (down from ₪2.42 in FY 2023). Revenue: ₪87.7m (down 33% from FY 2023). Net income: ₪2.87m (down 86% from FY 2023). Profit margin: 3.3% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.分析記事 • Mar 26Impressive Earnings May Not Tell The Whole Story For C-Lab (TLV:CLAB)C-Lab Ltd's ( TLV:CLAB ) stock was strong after they recently reported robust earnings. However, our analysis suggests...Reported Earnings • Mar 21Full year 2023 earnings released: EPS: ₪2.42 (vs ₪0.82 in FY 2022)Full year 2023 results: EPS: ₪2.42 (up from ₪0.82 in FY 2022). Revenue: ₪130.0m (up 9.0% from FY 2022). Net income: ₪20.5m (up 194% from FY 2022). Profit margin: 16% (up from 5.9% in FY 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.分析記事 • Mar 30We Think C-Lab's (TLV:CLAB) Robust Earnings Are ConservativeC-Lab Ltd's ( TLV:CLAB ) strong earnings report was rewarded with a positive stock price move. We have done some...Reported Earnings • Mar 25Full year 2022 earnings released: EPS: ₪0.82 (vs ₪0.14 in FY 2021)Full year 2022 results: EPS: ₪0.82 (up from ₪0.14 in FY 2021). Revenue: ₪119.3m (up 43% from FY 2021). Net income: ₪6.98m (up 493% from FY 2021). Profit margin: 5.9% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue.Reported Earnings • Mar 30Full year 2021 earnings released: EPS: ₪0.14 (vs ₪1.35 in FY 2020)Full year 2021 results: EPS: ₪0.14 (down from ₪1.35 in FY 2020). Revenue: ₪83.3m (down 21% from FY 2020). Net income: ₪1.18m (down 90% from FY 2020). Profit margin: 1.4% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue.すべての更新を表示Recent updates分析記事 • Jan 22C-Lab Ltd's (TLV:CLAB) 27% Price Boost Is Out Of Tune With RevenuesC-Lab Ltd ( TLV:CLAB ) shares have continued their recent momentum with a 27% gain in the last month alone. But the...分析記事 • Jan 15Calculating The Fair Value Of C-Lab Ltd (TLV:CLAB)Key Insights Using the 2 Stage Free Cash Flow to Equity, C-Lab fair value estimate is ₪12.10 With ₪11.70 share price...New Risk • Jan 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (₪99.2m market cap, or US$31.4m).お知らせ • Jan 13C-Lab Ltd, Annual General Meeting, Feb 16, 2026C-Lab Ltd, Annual General Meeting, Feb 16, 2026. Location: co. offices, IsraelBuy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 5.5% to ₪9.55. The fair value is estimated to be ₪12.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.分析記事 • Nov 12C-Lab Ltd's (TLV:CLAB) Business Is Trailing The Industry But Its Shares Aren'tThere wouldn't be many who think C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x is worth a mention...Buy Or Sell Opportunity • Sep 16Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₪9.38. The fair value is estimated to be ₪12.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.分析記事 • Aug 08Investors Could Be Concerned With C-Lab's (TLV:CLAB) Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...分析記事 • Jun 24C-Lab Ltd's (TLV:CLAB) Share Price Could Signal Some RiskIt's not a stretch to say that C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x right now seems quite...Reported Earnings • Mar 27Full year 2024 earnings released: EPS: ₪0.34 (vs ₪2.42 in FY 2023)Full year 2024 results: EPS: ₪0.34 (down from ₪2.42 in FY 2023). Revenue: ₪87.7m (down 33% from FY 2023). Net income: ₪2.87m (down 86% from FY 2023). Profit margin: 3.3% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.New Risk • Mar 09New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (₪107.5m market cap, or US$29.7m).分析記事 • Dec 09Cautious Investors Not Rewarding C-Lab Ltd's (TLV:CLAB) Performance CompletelyC-Lab Ltd's ( TLV:CLAB ) price-to-earnings (or "P/E") ratio of 6.3x might make it look like a strong buy right now...お知らせ • Dec 06C-Lab Ltd, Annual General Meeting, Jan 09, 2025C-Lab Ltd, Annual General Meeting, Jan 09, 2025. Location: co. offices, IsraelBoard Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Independent Director Yanir Farber was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to ₪10.60, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 38% over the past three years.分析記事 • Mar 26Impressive Earnings May Not Tell The Whole Story For C-Lab (TLV:CLAB)C-Lab Ltd's ( TLV:CLAB ) stock was strong after they recently reported robust earnings. However, our analysis suggests...分析記事 • Mar 22C-Lab Ltd's (TLV:CLAB) Shares Leap 26% Yet They're Still Not Telling The Full StoryDespite an already strong run, C-Lab Ltd ( TLV:CLAB ) shares have been powering on, with a gain of 26% in the last...分析記事 • Mar 21Why The 23% Return On Capital At C-Lab (TLV:CLAB) Should Have Your AttentionDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Reported Earnings • Mar 21Full year 2023 earnings released: EPS: ₪2.42 (vs ₪0.82 in FY 2022)Full year 2023 results: EPS: ₪2.42 (up from ₪0.82 in FY 2022). Revenue: ₪130.0m (up 9.0% from FY 2022). Net income: ₪20.5m (up 194% from FY 2022). Profit margin: 16% (up from 5.9% in FY 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.New Risk • Mar 19New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪145.7m market cap, or US$39.8m).Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪17.18, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Tech industry in Asia. Total returns to shareholders of 10% over the past three years.New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪119.4m market cap, or US$32.9m).Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₪13.57, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 19% over the past year.分析記事 • Dec 07We Like These Underlying Return On Capital Trends At C-Lab (TLV:CLAB)If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₪129.5m market cap, or US$34.1m).分析記事 • Aug 06C-Lab's (TLV:CLAB) Returns On Capital Are Heading HigherIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...分析記事 • Mar 30We Think C-Lab's (TLV:CLAB) Robust Earnings Are ConservativeC-Lab Ltd's ( TLV:CLAB ) strong earnings report was rewarded with a positive stock price move. We have done some...Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪16.81, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 15x in the Tech industry in Asia. Negligible returns to shareholders over past year.分析記事 • Mar 25Returns On Capital Are Showing Encouraging Signs At C-Lab (TLV:CLAB)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Reported Earnings • Mar 25Full year 2022 earnings released: EPS: ₪0.82 (vs ₪0.14 in FY 2021)Full year 2022 results: EPS: ₪0.82 (up from ₪0.14 in FY 2021). Revenue: ₪119.3m (up 43% from FY 2021). Net income: ₪6.98m (up 493% from FY 2021). Profit margin: 5.9% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue.お知らせ • Oct 03CompuLab Ltd. (TASE:CLAB) announces an Equity Buyback for ILS 1 million worth of its shares.CompuLab Ltd. (TASE:CLAB) announces a share repurchase program. Under the program, the company will repurchase up to ILS 1 million worth of its shares. The repurchases will be funded from company's cash balance. The plan will be valid till October 2, 2023.分析記事 • May 25Returns On Capital At CompuLab (TLV:CLAB) Paint A Concerning PictureThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Shai Tsabari was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 30Full year 2021 earnings released: EPS: ₪0.14 (vs ₪1.35 in FY 2020)Full year 2021 results: EPS: ₪0.14 (down from ₪1.35 in FY 2020). Revenue: ₪83.3m (down 21% from FY 2020). Net income: ₪1.18m (down 90% from FY 2020). Profit margin: 1.4% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue.分析記事 • May 25Optimistic Investors Push CompuLab Ltd. (TLV:CLAB) Shares Up 30% But Growth Is LackingCompuLab Ltd. ( TLV:CLAB ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₪20.06, the stock trades at a trailing P/E ratio of 14.9x. Average trailing P/E is 20x in the Tech industry in Asia.Reported Earnings • Mar 24Full year 2020 earnings released: EPS ₪1.35 (vs ₪0.64 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₪105.3m (down 1.8% from FY 2019). Net income: ₪11.5m (up 110% from FY 2019). Profit margin: 11% (up from 5.1% in FY 2019). The increase in margin was driven by lower expenses.収支内訳C-Lab の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TASE:CLAB 収益、費用、利益 ( )ILS Millions日付収益収益G+A経費研究開発費30 Jun 2575-3121331 Mar 25810131431 Dec 24883141530 Sep 241019141430 Jun 2411316151431 Mar 2412218151331 Dec 2313021151330 Sep 2312816151430 Jun 2312611151531 Mar 231239151531 Dec 221197141630 Sep 221085141530 Jun 22973131531 Mar 22902131431 Dec 21831121430 Sep 21851121430 Jun 21861121431 Mar 21966131531 Dec 2010511131530 Sep 2011012141530 Jun 2011513141531 Mar 201119141531 Dec 191075141431 Dec 18971141331 Dec 17730101131 Dec 1685511830 Sep 1682211831 Dec 1510801412質の高い収益: CLABは現在利益が出ていません。利益率の向上: CLABは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: CLABは利益を出していないが、過去 5 年間で年間0.05%の割合で損失を削減してきた。成長の加速: CLABの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: CLABは利益が出ていないため、過去 1 年間の収益成長をTech業界 ( 13.3% ) と比較することは困難です。株主資本利益率高いROE: CLABは現在利益が出ていないため、自己資本利益率 ( -3.45% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YTech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/02/11 03:36終値2026/02/03 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋C-Lab Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Mar 27Full year 2024 earnings released: EPS: ₪0.34 (vs ₪2.42 in FY 2023)Full year 2024 results: EPS: ₪0.34 (down from ₪2.42 in FY 2023). Revenue: ₪87.7m (down 33% from FY 2023). Net income: ₪2.87m (down 86% from FY 2023). Profit margin: 3.3% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
分析記事 • Mar 26Impressive Earnings May Not Tell The Whole Story For C-Lab (TLV:CLAB)C-Lab Ltd's ( TLV:CLAB ) stock was strong after they recently reported robust earnings. However, our analysis suggests...
Reported Earnings • Mar 21Full year 2023 earnings released: EPS: ₪2.42 (vs ₪0.82 in FY 2022)Full year 2023 results: EPS: ₪2.42 (up from ₪0.82 in FY 2022). Revenue: ₪130.0m (up 9.0% from FY 2022). Net income: ₪20.5m (up 194% from FY 2022). Profit margin: 16% (up from 5.9% in FY 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
分析記事 • Mar 30We Think C-Lab's (TLV:CLAB) Robust Earnings Are ConservativeC-Lab Ltd's ( TLV:CLAB ) strong earnings report was rewarded with a positive stock price move. We have done some...
Reported Earnings • Mar 25Full year 2022 earnings released: EPS: ₪0.82 (vs ₪0.14 in FY 2021)Full year 2022 results: EPS: ₪0.82 (up from ₪0.14 in FY 2021). Revenue: ₪119.3m (up 43% from FY 2021). Net income: ₪6.98m (up 493% from FY 2021). Profit margin: 5.9% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue.
Reported Earnings • Mar 30Full year 2021 earnings released: EPS: ₪0.14 (vs ₪1.35 in FY 2020)Full year 2021 results: EPS: ₪0.14 (down from ₪1.35 in FY 2020). Revenue: ₪83.3m (down 21% from FY 2020). Net income: ₪1.18m (down 90% from FY 2020). Profit margin: 1.4% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue.
分析記事 • Jan 22C-Lab Ltd's (TLV:CLAB) 27% Price Boost Is Out Of Tune With RevenuesC-Lab Ltd ( TLV:CLAB ) shares have continued their recent momentum with a 27% gain in the last month alone. But the...
分析記事 • Jan 15Calculating The Fair Value Of C-Lab Ltd (TLV:CLAB)Key Insights Using the 2 Stage Free Cash Flow to Equity, C-Lab fair value estimate is ₪12.10 With ₪11.70 share price...
New Risk • Jan 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (₪99.2m market cap, or US$31.4m).
お知らせ • Jan 13C-Lab Ltd, Annual General Meeting, Feb 16, 2026C-Lab Ltd, Annual General Meeting, Feb 16, 2026. Location: co. offices, Israel
Buy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 5.5% to ₪9.55. The fair value is estimated to be ₪12.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.
分析記事 • Nov 12C-Lab Ltd's (TLV:CLAB) Business Is Trailing The Industry But Its Shares Aren'tThere wouldn't be many who think C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x is worth a mention...
Buy Or Sell Opportunity • Sep 16Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₪9.38. The fair value is estimated to be ₪12.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.
分析記事 • Aug 08Investors Could Be Concerned With C-Lab's (TLV:CLAB) Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
分析記事 • Jun 24C-Lab Ltd's (TLV:CLAB) Share Price Could Signal Some RiskIt's not a stretch to say that C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x right now seems quite...
Reported Earnings • Mar 27Full year 2024 earnings released: EPS: ₪0.34 (vs ₪2.42 in FY 2023)Full year 2024 results: EPS: ₪0.34 (down from ₪2.42 in FY 2023). Revenue: ₪87.7m (down 33% from FY 2023). Net income: ₪2.87m (down 86% from FY 2023). Profit margin: 3.3% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
New Risk • Mar 09New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (₪107.5m market cap, or US$29.7m).
分析記事 • Dec 09Cautious Investors Not Rewarding C-Lab Ltd's (TLV:CLAB) Performance CompletelyC-Lab Ltd's ( TLV:CLAB ) price-to-earnings (or "P/E") ratio of 6.3x might make it look like a strong buy right now...
お知らせ • Dec 06C-Lab Ltd, Annual General Meeting, Jan 09, 2025C-Lab Ltd, Annual General Meeting, Jan 09, 2025. Location: co. offices, Israel
Board Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Independent Director Yanir Farber was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to ₪10.60, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 38% over the past three years.
分析記事 • Mar 26Impressive Earnings May Not Tell The Whole Story For C-Lab (TLV:CLAB)C-Lab Ltd's ( TLV:CLAB ) stock was strong after they recently reported robust earnings. However, our analysis suggests...
分析記事 • Mar 22C-Lab Ltd's (TLV:CLAB) Shares Leap 26% Yet They're Still Not Telling The Full StoryDespite an already strong run, C-Lab Ltd ( TLV:CLAB ) shares have been powering on, with a gain of 26% in the last...
分析記事 • Mar 21Why The 23% Return On Capital At C-Lab (TLV:CLAB) Should Have Your AttentionDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Reported Earnings • Mar 21Full year 2023 earnings released: EPS: ₪2.42 (vs ₪0.82 in FY 2022)Full year 2023 results: EPS: ₪2.42 (up from ₪0.82 in FY 2022). Revenue: ₪130.0m (up 9.0% from FY 2022). Net income: ₪20.5m (up 194% from FY 2022). Profit margin: 16% (up from 5.9% in FY 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
New Risk • Mar 19New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪145.7m market cap, or US$39.8m).
Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪17.18, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Tech industry in Asia. Total returns to shareholders of 10% over the past three years.
New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪119.4m market cap, or US$32.9m).
Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₪13.57, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 19% over the past year.
分析記事 • Dec 07We Like These Underlying Return On Capital Trends At C-Lab (TLV:CLAB)If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₪129.5m market cap, or US$34.1m).
分析記事 • Aug 06C-Lab's (TLV:CLAB) Returns On Capital Are Heading HigherIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
分析記事 • Mar 30We Think C-Lab's (TLV:CLAB) Robust Earnings Are ConservativeC-Lab Ltd's ( TLV:CLAB ) strong earnings report was rewarded with a positive stock price move. We have done some...
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪16.81, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 15x in the Tech industry in Asia. Negligible returns to shareholders over past year.
分析記事 • Mar 25Returns On Capital Are Showing Encouraging Signs At C-Lab (TLV:CLAB)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Reported Earnings • Mar 25Full year 2022 earnings released: EPS: ₪0.82 (vs ₪0.14 in FY 2021)Full year 2022 results: EPS: ₪0.82 (up from ₪0.14 in FY 2021). Revenue: ₪119.3m (up 43% from FY 2021). Net income: ₪6.98m (up 493% from FY 2021). Profit margin: 5.9% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue.
お知らせ • Oct 03CompuLab Ltd. (TASE:CLAB) announces an Equity Buyback for ILS 1 million worth of its shares.CompuLab Ltd. (TASE:CLAB) announces a share repurchase program. Under the program, the company will repurchase up to ILS 1 million worth of its shares. The repurchases will be funded from company's cash balance. The plan will be valid till October 2, 2023.
分析記事 • May 25Returns On Capital At CompuLab (TLV:CLAB) Paint A Concerning PictureThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Shai Tsabari was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 30Full year 2021 earnings released: EPS: ₪0.14 (vs ₪1.35 in FY 2020)Full year 2021 results: EPS: ₪0.14 (down from ₪1.35 in FY 2020). Revenue: ₪83.3m (down 21% from FY 2020). Net income: ₪1.18m (down 90% from FY 2020). Profit margin: 1.4% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue.
分析記事 • May 25Optimistic Investors Push CompuLab Ltd. (TLV:CLAB) Shares Up 30% But Growth Is LackingCompuLab Ltd. ( TLV:CLAB ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...
Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₪20.06, the stock trades at a trailing P/E ratio of 14.9x. Average trailing P/E is 20x in the Tech industry in Asia.
Reported Earnings • Mar 24Full year 2020 earnings released: EPS ₪1.35 (vs ₪0.64 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₪105.3m (down 1.8% from FY 2019). Net income: ₪11.5m (up 110% from FY 2019). Profit margin: 11% (up from 5.1% in FY 2019). The increase in margin was driven by lower expenses.